Table 2.
Overview of Cohort Studies and Largest Published Data Sets on Kidney, Liver, Heart, and Lung Transplant Recipients Infected With SARS-CoV-2
| Author | Study Design | Origin | Patients, No. | Transplanted Organ(s) | Mortality Rate, % |
|---|---|---|---|---|---|
| Coll et al. [177] | Multicenter cohort study | Europe | 665 | Kidney/liver/heart/lung/other | 23.5 |
| Kute et al. [179] | Multicenter cohort study | Asia | 250 | Kidney | 11.6 |
| Azzi et al. [118] | Cohort study | North America | 229 | Kidney | 20.5 |
| Webb et al. [184] | Multicenter cohort study | Other | 151 | Liver | 18.5 |
| Cravedi et al. [127] | Cohort study | North America | 144 | Kidney | 31.9 |
| Favà et al. [131] | Cohort study | Europe | 104 | Kidney | 26.9 |
| Molnar et al. [180] | Cohort study | North America | 98 | Kidney/liver/heart/lung/other | 39.8 |
| Ozturk et al. [181] | Multicenter cohort study | Asia | 81 | Kidney | 11.1 |
| Craig-Schapiro et al. [126] | Cohort study | North America | 80 | Kidney | 16.3 |
| Ali et al. [117] | Cohort study | Asia | 67 | Kidney/liver/lung | 3.0 |
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.